Literature DB >> 17335995

Effect of Mitragyna speciosa aqueous extract on ethanol withdrawal symptoms in mice.

Ekkasit Kumarnsit1, Niwat Keawpradub, Watcharin Nuankaew.   

Abstract

Administration of the aqueous extract of Mitragyna speciosa at a dose of 300 mg/kg significantly inhibited ethanol withdrawal-induced behaviors that included rearing, displacement and head weaving. The results also showed that at doses of 100, 300 and 500 mg/kg M. speciosa showed antidepressant activity without effect on the spontaneous motor activity.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17335995     DOI： 10.1016/j.fitote.2006.11.012

Source DB:  PubMed          Journal:  Fitoterapia        ISSN： 0367-326X            Impact factor:   2.882


  11 in total

Review 1.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

2.  Methanolic extract of Mitragyna speciosa Korth leaf inhibits ethanol seeking behaviour in mice: involvement of antidopaminergic mechanism.

Authors:  Kamini Vijeepallam; Vijayapandi Pandy; Dharmani Devi Murugan; Murali Naidu
Journal:  Metab Brain Dis       Date:  2019-08-08       Impact factor: 3.584

3.  Behavioural and Electrophysiological Evidence of Impaired Learning and Memory in Male Sprague Dawley Rats following Subchronic Exposure to Standardised Methanolic Extract of Mitragyna speciosa Korth.

Authors:  Mohd Ulul Ilmie; Sharif Mahsufi Mansor; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2015-12

4.  Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish.

Authors:  Beng-Siang Khor; Mohd Fadzly Amar Jamil; Mohamad Ilham Adenan; Alexander Chong Shu-Chien
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

5.  Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Jun Lu; Heming Wei; Jianjun Wu; Mohd Fadzly Amar Jamil; Mei Lan Tan; Mohd Ilham Adenan; Philip Wong; Winston Shim
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

6.  Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice.

Authors:  Kamini Vijeepallam; Vijayapandi Pandy; Thubasni Kunasegaran; Dharmani D Murugan; Murali Naidu
Journal:  Front Pharmacol       Date:  2016-12-06       Impact factor: 5.810

Review 7.  The Potential for Kratom as an Antidepressant and Antipsychotic.

Authors:  Lindsay E Johnson; Lilian Balyan; Amy Magdalany; Fizza Saeed; Robert Salinas; Starla Wallace; Charles A Veltri; Marc T Swogger; Zach Walsh; Oliver Grundmann
Journal:  Yale J Biol Med       Date:  2020-06-29

8.  Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system.

Authors:  Abdul Rahman Shamima; Sharida Fakurazi; Mohamad Taufik Hidayat; Ithnin Hairuszah; Mohamad Aris Mohd Moklas; Palanisamy Arulselvan
Journal:  Int J Mol Sci       Date:  2012-09-12       Impact factor: 6.208

9.  Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.

Authors:  Alicia G Lydecker; Abhisheak Sharma; Christopher R McCurdy; Bonnie A Avery; Kavita M Babu; Edward W Boyer
Journal:  J Med Toxicol       Date:  2016-10-17

Review 10.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.